Health occupations: emergency medical services personnel; access to opioid antagonists; provide to life support agencies under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 20911.
Summary
House Bill 4417 would amend Michigan’s Public Health Code to require the Department of Health and Human Services, when it distributes opioid antagonists at no cost to individuals for overdose prevention, to also provide an opioid antagonist at no cost directly to a life support agency upon request. The purpose is to equip life support vehicles with opioid antagonists so emergency medical personnel can respond more effectively to opioid-related overdoses.
The bill is narrowly focused on expanding access to overdose-reversal medication in the emergency response system. It does not create a new licensing program or change the underlying rules for opioid antagonist distribution generally; instead, it adds a specific obligation for the department to supply these medications to life support agencies for use in designated vehicles under the Public Health Code.
Impact
HB 4417 would add section 20911 to the Public Health Code and create a statutory requirement that the department provide opioid antagonists free of charge to life support agencies when requested, in addition to existing free distribution to individuals. This would affect state public health operations and emergency medical services by ensuring life support vehicles can be stocked with overdose-reversal medication, potentially improving response times and overdose survival outcomes. The bill specifically references life support vehicles described in section 20919(1)(k), tying the new requirement to existing EMS statutory definitions and equipment standards.
Sentiment
The available voting history suggests strong bipartisan support for the bill. It was reported from committee without amendment on a 13-0 vote and later passed the House on third reading by a wide margin, 100-4, with immediate effect. That pattern indicates broad agreement that expanding access to opioid antagonists for emergency responders is a practical public health measure.
Contention
There is little evidence of substantive controversy in the available record, and no committee transcript excerpts were provided. The only apparent points of possible concern would be the added administrative and supply obligations on the department and the policy choice to mandate free distribution to life support agencies, but the recorded votes show these issues did not generate significant opposition. The four negative votes on final passage suggest limited dissent, though the record does not identify the specific objections.